HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

Digital Health

Digital Health Radcliffe Cardiology

Introducing heart rate variability monitoring combined with

HRX 22

Machine learning predicts the risk of hemorrhagic transformation

Advancing Solutions to the Carbohydrate Sequencing Challenge

Remote sensing of vital signs by medical radar time-series signal

YMJ :: Yonsei Medical Journal

Labbook 2022